Elizabeth Joan Shane MD
Osteoporosis & Bone Metabolism Medicine, Parathyroid
Professor of Medicine at Columbia University Medical Center
Join to View Full Profile
180 Fort Washington AvenueNew York, NY 10032
Dr. Shane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elizabeth Shane is an endocrinologist based in New York, NY, with subspecialties in osteoporosis and bone metabolism medicine, and parathyroid disorders. She completed her fellowship and residency at New York Presbyterian Hospital (Columbia Campus) after earning her medical degree from the University of Toronto Faculty of Medicine in 1975. Her work focuses on osteoporosis and metabolic bone disease, and she has authored several publications in prominent journals, including research on osteoporosis and bone fragility. Dr. Shane has conducted clinical trials on bone loss prevention and vitamin D, and received multiple CMS Meaningful Use certifications for EHR systems. She was recognized as a Top Doctor in the New York Metro Area by Castle Connolly from 2002 to 2014.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1981- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1976 - 1978
University of Toronto Faculty of MedicineClass of 1975
Certifications & Licensure
NY State Medical License 1979 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017
Clinical Trials
- Osteoporosis Prevention After Heart Transplant Start of enrollment: 1997 Sep 01
- Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation Start of enrollment: 2005 Nov 01
- Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women Start of enrollment: 2008 Aug 20
Publications & Presentations
PubMed
- Elderly Caribbean Hispanic men have lower tibial stiffness and failure load compared to non-Hispanic White and Black men.Sanchita Agarwal, Ragyie Rawal, Carmen Germosen, Isabella Rosillo, Lynette X Lopez
JBMR Plus. 2025-09-01 - 5 citationsBisphosphonates Maintain BMD After Sequential Teriparatide and Denosumab in Premenopausal Women with Idiopathic Osteoporosis.Mafo Kamanda-Kosseh, Stephanie Shiau, Sanchita Agarwal, Ananya Kondapalli, Ivelisse Colon
The Journal of Clinical Endocrinology and Metabolism. 2025-02-18 - 2 citationsHR-pQCT reveals marked trabecular and cortical structural deficits in women with pregnancy and lactation-associated osteoporosis (PLO).Sanchita Agarwal, Dany El-Najjar, Ananya Kondapalli, Nayoung Kil, Mafo Kamanda-Kosseh
Journal of Bone and Mineral Research. 2024-12-31
Journal Articles
- Disrupted Radial and Tibial Microarchitecture in Patients with Monoclonal Gammopathy of Undetermined SignificanceE Shane, E M Stein, S Lentzsch, J Fu, Osteoporosis international
- Abnormal Microarchitecture and Stiffness in Postmenopausal Women Using Chronic Inhaled GlucocorticoidsE Dimango, E Shane, E M Stein, Osteoporosis international
Press Mentions
Hypercalcemia—a ReviewOctober 25th, 2022- Rarity Complicates Research, Treatment for Unexplained Premenopausal OsteoporosisMarch 10th, 2021
Crisis in the Treatment of OsteoporosisJune 23rd, 2016
Grant Support
- Subchondral Trabecular Plate and Rod Abnormalities in Human OsteoarthritisCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
- Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trialMAYO CLINIC ROCHESTER2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
